Medicine and Dentistry
Systemic Scleroderma
100%
Dermatosis
50%
Therapeutic Procedure
50%
Comprehension
33%
Morbidity
16%
Diseases
16%
Biological Marker
16%
Pathogenesis
16%
Cyclophosphamide
16%
Cohort Analysis
16%
Disease Course
16%
Methotrexate
16%
Immunoglobulin
16%
Azathioprine
16%
Mortality
16%
Mycophenolic Acid
16%
Patient
16%
Motivation
16%
Pharmacology, Toxicology and Pharmaceutical Science
Systemic Sclerosis
100%
Skin Disease
50%
Diseases
16%
Cyclophosphamide
16%
Methotrexate
16%
Immunoglobulin
16%
Morbidity
16%
Pathogenesis
16%
Biological Marker
16%
Disease Course
16%
Azathioprine
16%
Mortality
16%
Mycophenolate Mofetil
16%
Immunology and Microbiology
Systemic Scleroderma
100%
Skin
50%
Comprehension
33%
Morbidity
16%
Intravenous Immunoglobulin
16%
Azathioprine
16%
Cyclophosphamide
16%
Methotrexate
16%
Mycophenolic Acid
16%
Mortality
16%
INIS
skin diseases
50%
reviews
33%
patients
16%
diseases
16%
mortality
16%
pathogenesis
16%
biological markers
16%
morbidity
16%
incidents
16%
immunoglobulins
16%
methotrexate
16%
cyclophosphamide
16%